Cargando…
Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancer
Programmed cell death-ligand 1 (PD-L1) on tumor cells can be degraded to soluble form (sPD-L1) and enter circulation, however, the clinical significances of sPD-L1 in peripheral blood remains to be elucidated in non-small-cell lung cancer (NSCLC). We monitored plasma sPD-L1 levels during perioperati...
Autores principales: | Teramoto, Koji, Igarashi, Tomoyuki, Kataoka, Yoko, Ishida, Mitsuaki, Hanaoka, Jun, Sumimoto, Hidetoshi, Daigo, Yataro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576714/ https://www.ncbi.nlm.nih.gov/pubmed/37646826 http://dx.doi.org/10.1007/s00262-023-03527-y |
Ejemplares similares
-
Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors
por: Igarashi, Tomoyuki, et al.
Publicado: (2016) -
Oncogenic epidermal growth factor receptor signal-induced histone deacetylation suppresses chemokine gene expression in human lung adenocarcinoma
por: Sumimoto, Hidetoshi, et al.
Publicado: (2023) -
RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers
por: Sumimoto, Hidetoshi, et al.
Publicado: (2016) -
Hypoxia-induced galectin-3 enhances RhoA function to activate the motility of tumor cells in non-small cell lung cancer
por: Kataoka, Yoko, et al.
Publicado: (2019) -
Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients
por: Sumimoto, Hidetoshi, et al.
Publicado: (2021)